News

Treatment options available for patients ... 1 720 777 7457 Fax: +1 720 777 7277 [email protected]. Eosinophilic esophagitis (EoE) presents with a constellation of symptoms including feeding ...
Eosinophilic esophagitis (EoE) is a long-term immune ... There's no cure for EoE. But treatment can help you manage the inflammation that causes symptoms. The main ways to do that are with diet ...
Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...
Eupraxia Pharmaceuticals Inc.’s EPRX share price has surged by 5.46%, which has investors questioning if this is right time ...
NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.
Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious ...
Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...
On its way to generating sales of $14 billion in just its seventh full year on the market, Sanofi and Regeneron’s Dupixent ...